Literature DB >> 19793944

Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screening.

F A Miller1, R Z Hayeems, Y Bombard, J Little, J C Carroll, B Wilson, J Allanson, M Paynter, J P Bytautas, R Christensen, P Chakraborty.   

Abstract

BACKGROUND: Expanded newborn screening generates incidental results, notably carrier results. Yet newborn screening programmes typically restrict parental choice regarding receipt of this non-health serving genetic information. Healthcare providers play a key role in educating families or caring for screened infants and have strong beliefs about the management of incidental results.
METHODS: To inform policy on disclosure of infant sickle cell disorder (SCD) carrier results, a mixed-methods study of healthcare providers was conducted in Ontario, Canada, to understand attitudes regarding result management using a cross-sectional survey (N = 1615) and semistructured interviews (N = 42).
RESULTS: Agreement to reasons favouring disclosure of SCD carrier results was high (65.1%-92.7%) and to reasons opposing disclosure was low (4.1%-18.1%). Genetics professionals expressed less support for arguments favouring disclosure (35.3%-78.8%), and more agreement with arguments opposing disclosure (15.7%-51.9%). A slim majority of genetics professionals (51.9%) agreed that a reason to avoid disclosure was the importance of allowing the child to decide to receive results. Qualitatively, there was a perceived "duty" to disclose, that if the clinician possessed the information, the clinician could not withhold it. DISCUSSION: While a majority of respondents perceived a duty to disclose the incidental results of newborn screening, the policy implications of these attitudes are not obvious. In particular, policy must balance descriptive ethics (ie, what providers believe) and normative ethics (ie, what duty-based principles oblige), address dissenting opinion and consider the relevance of moral principles grounded in clinical obligations for public health initiatives.

Entities:  

Mesh:

Year:  2009        PMID: 19793944     DOI: 10.1136/jme.2009.030346

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  12 in total

1.  Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Brenda J Wilson; June C Carroll; Martha Paynter; Julian Little; Judith Allanson; Jessica P Bytautas; Pranesh Chakraborty
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

Review 2.  To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.

Authors:  Gabrielle M Christenhusz; Koenraad Devriendt; Kris Dierickx
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

3.  Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.

Authors:  Galen Joseph; Flavia Chen; Julie Harris-Wai; Jennifer M Puck; Charlotte Young; Barbara A Koenig
Journal:  Pediatrics       Date:  2016-01       Impact factor: 7.124

Review 4.  Incidental findings from clinical genome-wide sequencing: a review.

Authors:  Z Lohn; S Adam; P H Birch; J M Friedman
Journal:  J Genet Couns       Date:  2013-05-26       Impact factor: 2.537

5.  Primary care role in expanded newborn screening: After the heel prick test.

Authors:  Robin Z Hayeems; Fiona A Miller; June C Carroll; Julian Little; Judith Allanson; Jessica P Bytautas; Pranesh Chakraborty; Brenda J Wilson
Journal:  Can Fam Physician       Date:  2013-08       Impact factor: 3.275

6.  Effort required to contact primary care providers after newborn screening identifies sickle cell trait.

Authors:  Stephanie A Christopher; Jenelle L Collins; Michael H Farrell
Journal:  J Natl Med Assoc       Date:  2012 Nov-Dec       Impact factor: 1.798

7.  Prenatal healthcare providers' Gaucher disease carrier screening practices.

Authors:  Dana Falcone; Elisabeth McCarty Wood; Michael Mennuti; Sharon X Xie; Vivianna M Van Deerlin
Journal:  Genet Med       Date:  2012-05-31       Impact factor: 8.822

8.  Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening.

Authors:  Sara D Khangura; Beth K Potter; Christine Davies; Robin Ducharme; A Brianne Bota; Steven Hawken; Kumanan Wilson; Maria D Karaceper; Robert J Klaassen; Julian Little; Ewurabena Simpson; Pranesh Chakraborty
Journal:  BMC Pediatr       Date:  2021-07-01       Impact factor: 2.125

Review 9.  Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics.

Authors:  Tessel Rigter; Lidewij Henneman; Ulf Kristoffersson; Alison Hall; Helger G Yntema; Pascal Borry; Holger Tönnies; Quinten Waisfisz; Mariet W Elting; Wybo J Dondorp; Martina C Cornel
Journal:  Hum Mutat       Date:  2013-07-16       Impact factor: 4.878

10.  Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2016.

Authors:  Josefina Aparecida Pellegrini Braga; Mônica Pinheiro de Almeida Veríssimo; Sara Teresinha Olalla Saad; Rodolfo Delfini Cançado; Sandra Regina Loggetto
Journal:  Rev Bras Hematol Hemoter       Date:  2016-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.